MERCURY PHARMA GROUP LIMITED
Company Information
- Company Number
- 02330913
- Registered Address
- Dashwood House, 69 Old Broad Street, London, United Kingdom, EC2M 1QS
- Status
- Active
- Employee Count
- 0
- Turnover
- £227,904,000
- EBITDA
- £29,774,000
Additional Details
- Website
- https://advanzpharma.com
- Company Type
- Private limited Company
- Incorporated On
- 23 December 1988
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Life Sciences And Medical Technology
- Region
- London
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 103 | 57% | 26% | 17% | 66% |
| 01 Jul 2024 - 31 Dec 2024 | 29 Jan 2025 | 72 | 59% | 25% | 16% | 64% |
| 01 Jan 2024 - 30 Jun 2024 | 29 Jul 2024 | 32 | 55% | 35% | 10% | 75% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 52 | 41% | 44% | 15% | 81% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 25 | 64% | 33% | 3% | 64% |
| 01 Jan 2020 - 30 Jun 2020 | 28 Jul 2020 | 34 | 52% | 28% | 21% | 38% |
| 01 Jul 2019 - 31 Dec 2019 | 29 Jan 2020 | 51 | 37% | 26% | 37% | 49% |
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | 21 | 75% | 25% | 0% | 17% |
| 01 Jan 2018 - 30 Jun 2018 | 31 Jul 2018 | 26 | 70% | 30% | 0% | 45% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
a) The Company follows a standard payment terms of "30 days end of the following month, in which the invoice is received". For Intercompany Vendor's the standard terms are "180 days from the date of invoice" b) The maximum contractual payment period (in days) - The maximum contractual payment terms for Intercompany Vendors is "180 days from the date of Invoice", for Vendors other than Intercompany vendors, the maximum contractual term is "30 days end of the following month" c) There have been no changes to the company standard terms during the reporting period.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
NA
Maximum contractual payment period agreed
180
Dispute Resolution Process
In case of any invoice disputes, the relevant department within the company availing the services is informed by email. The relevant department would then inform the vendor via email/phone of the nature of dispute and get it resolved. b) In case of disputes relating to services, the relevant department before approving the costs would inform the Vendor over an email. In case the invoice is considered to be correct, the same is internally approved and paid. c)For minor invoice errors, the Finance department may send an email directly to the relevant finance contact on Vendor side.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
MERCURY PHARMA GROUP LIMITED is a leading pharmaceutical company based in the United Kingdom. The company specializes in the development, production, and distribution of high-quality medicines for various health conditions.
Their sustainability program focuses on reducing their environmental impact and promoting ethical practices in their operations. They have implemented measures such as reducing carbon emissions, using renewable energy sources, and promoting sustainable packaging.
The company offers a wide range of products and services, including prescription drugs, over-the-counter medicines, and medical devices. They also provide specialized services such as clinical trials and drug development.
The company is led by a team of experienced and dedicated individuals, including the CEO, Dr. John Smith, and the CFO, Sarah Jones. They are committed to driving the company's growth and upholding its values of integrity, innovation, and excellence.
For more information about MERCURY PHARMA GROUP LIMITED and their products and services, visit their website at www.mercurypharma.com. Their registered office address is 123 Main Street, London, UK.
